Breaking News

VistaGen Therapeutics Inc (VTGN)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

3.030 -0.140 -4.42%

25/08 - Closed. Currency in USD

After Hours

3.118

+0.088

+2.904%

23:55:19 - Real-time Data

Type: Equity

Market: United States

Volume: 266,705
Bid/Ask: 0.000 / 0.000
Day's Range: 3.010 - 3.194

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

VistaGen Therapeutics Inc Company Profile

Get an in-depth profile of VistaGen Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company’s product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase II clinical trial to treat major depressive disorder. It also develops PH80, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase II clinical trial for the treatment of vasomotor symptoms, including hot flashes due to menopause, premenstrual dysphoric disorder, and other women’s health disorders; PH15, an investigational pherine nasal spray, which is in Phase II clinical trial for the treatment to improve cognitive impairment caused by mental fatigue and potentially other disorders; PH284, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase II clinical trial to treat loss of appetite associated with chronic disorders, such as cancer or heart disease, as well as cachexia; and AV-101, an oral prodrug that targets N-methyl-D-aspartate receptor in the brain for treating depression and neurological disorders. In addition, the company’s clinical-stage pipeline consists of intranasal product candidates comprising pherines. It has a license and collaboration agreement with AffaMed Therapeutics, Inc. to develop, manufacture, and commercialize fasedienol for multiple anxiety-related disorders. Vistagen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.

Contact Information

Address 343 Allerton Avenue
South San Francisco, 94080
United States

Phone 650 577 3600

Fax -

Web www.vistagen.com

Top Executives

Name	Age	Since	Title
Gordon Keller	-	2022	Chairman of Scientific Advisory Board
Sanjay Johan Mathew	-	2016	Member of Clinical & Regulatory Advisory Board
Jerry B. Gin	80	2016	Independent Director
Thomas P. Laughren	-	2016	Member of Clinical & Regulatory Advisory Board
Mary L. Rotunno	63	2021	Independent Director
Margaret M. FitzPatrick	57	2021	Independent Chair of the Board
Gerard Sanacora	-	2015	Member of Clinical & Regulatory Advisory Board
Maurizio Fava	-	2015	Member of Clinical & Regulatory Advisory Board
Michael B. Liebowitz	-	2018	Member of CNS Clinical and Regulatory Advisory Board
Joanne Curley	55	2021	Independent Director
Mark Steven Wallace	-	2017	Member of Clinical & Regulatory Advisory Board
Ann Michelle Cunningham	56	2019	Director
Shawn K. Singh	62	2009	President, CEO & Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

VTGN Comments

Write your thoughts about VistaGen Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,163.01	+10.02	+0.19%
NSE All Share	141,699.94	+260.18	+0.18%
US 30	45,199.0	-83.5	-0.18%
US 500	6,429.2	-10.1	-0.16%
FTSE 100	9,272.85	-48.55	-0.52%
DAX	24,158.60	-102.99	-0.42%
South Africa Top 40	94,799.90	-529.41	-0.56%

Brent Oil	67.15	-1.07	-1.57%
Crude Oil WTI	63.66	-1.14	-1.76%
Gold	3,426.62	+9.12	+0.27%
Silver	38.528	-0.175	-0.45%
Copper	4.5180	-0.0305	-0.67%
London Cocoa	5,332.00	-26.00	-0.49%
London Wheat	168.05	-1.25	-0.74%

Nigeria 10Y	15.681	0.00	0.00%
Nigeria 2Y	16.836	+0.000	+0.00%
U.K. 10Y	4.7400	+0.0450	+0.96%
Germany 10Y	2.7390	-0.0190	-0.69%
U.S. 10Y	4.278	+0.003	+0.07%
U.S. 5Y	3.775	-0.012	-0.32%
U.S. 2Y	3.704	-0.026	-0.70%

Fidelitybk	21.200	+0.350	+1.68%
Zenith Bank	70.40	+0.40	+0.57%
UBA	48.30	+0.35	+0.73%
First HoldCo	32.50	0.00	0.00%
Guaranty Trust Holding	98.00	+1.95	+2.03%
Sterling Bank	7.850	+0.150	+1.95%
Dangote Cement	517.00	-3.00	-0.58%

Recent Quotes

Name	Price	Chg.	Chg. %
VTGN	3.030	-0.140	-4.42%
WST	213.40	+0.50	+0.23%
Euromobiliare Eur.	5.967	+0.051	+0.86%
TAVE	1,210.00	-20.60	-1.67%
7887	6,930.0	0.0	0.00%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	10.700	-1.83%	59.42M
Guaranty Trust Holding	97.65	+1.67%	6.37M
ETI	36.45	-7.02%	5.57M
Oando Plc	54.00	+6.93%	4.80M
Zenith Bank	70.40	+0.57%	2.97M
MTN Nigeria	413.00	-5.06%	1.46M
Aradel Holdings	503.00	-1.37%	631.20K

Name	Last	Chg. %	Vol.
Ncr Nigeria	11.55	+10.00%	138.40K
SCOA Nigeria	6.050	+10.00%	109.10K
Airtel Africa	2,541.50	+10.00%	93.00
Livingtrust Mortgage Bank	4.62	+10.00%	15.00K
Union Dicon Salt	12.30	+9.82%	47.20K
Cornerst	7.78	+9.58%	280.56K
McNichols	3.81	+8.86%	441.35K

Name	Last	Chg. %	Vol.
Okomu Oil Palm	918.00	-10.00%	103.67K
Tripple Gee and Co	5.04	-10.00%	37.11K
Total Nig	576.00	-10.00%	8.05K
Chellarams	9.45	-10.00%	13.89K
Geregu Power	1,027.40	-10.00%	0.67K
Transcorp Power	257.90	-9.98%	25.91K
Nigerian Enamelware PLC	35.20	-9.74%	1.02K